CVS HEALTH REPORTS STRONG SECOND QUARTER RESULTS, RAISES 2022 FULL-YEAR EPS AND CASH FLOW FROM OPERATIONS GUIDANCE

Go back to CVS HEALTH REPORTS STRONG SECOND QUARTER RESULTS, RAISES 2022 FULL-YEAR EPS AND CASH FLOW FROM OPERATIONS GUIDANCE
CVS Caremark Corp. (NYSE: CVS) Delayed: 102.57 +4.25 (4.32%)
Previous Close $98.32    52 Week High $106.67 
Open $99.79    52 Week Low $69.30 
Day High $102.64    P/E 27.35 
Day Low $99.00    EPS $3.75 
Volume 1,606,208